Liver X receptors (LXRs) activate triglyceride synthesis in liver directly and indirectly by inducing sterol regulatory element-binding protein-1c (SREBP-1c). When administered to wild-type mice, the LXR activator T0901317 produces a mild and transient hypertriglyceridemia. Here, we show that T0901317 produces massive hypertriglyceridemia when given to mice lacking LDL receptors (LDLR-/- mice). Triglycerides ranged from 4000-6000 mg/dl, and the plasma turned milky. The median diameter of VLDL particles, measured by electron microscopy, increased from 60 to 112 nm, 87 % exceeding 80 nm, the size o
The oxysterol-activated liver X receptor (LXR) provides a link between sterol and fatty acid metabol...
The oxysterol-activated liver X receptor (LXR) provides a link between sterol and fatty acid metabol...
Objective: Pharmacological LXR activation has anti-atherosclerotic actions in animal models. Part of...
The oxysterol-activated liver X receptor (LXR) provides a link between sterol and fatty acid metabol...
The oxysterol-activated liver X receptor (LXR) provides a link between sterol and fatty acid metabol...
The nuclear liver X receptor (LXR) regulates multiple aspects of cholesterol, triacylglycerol (TG), ...
The nuclear liver X receptor (LXR) regulates multiple aspects of cholesterol, triacylglycerol (TG), ...
The nuclear liver X receptor (LXR) regulates multiple aspects of cholesterol, triacylglycerol (TG), ...
The nuclear liver X receptor (LXR) regulates multiple aspects of cholesterol, triacylglycerol (TG), ...
International audienceThis study explores the mechanisms responsible for the fatty liver setup in mi...
International audienceThis study explores the mechanisms responsible for the fatty liver setup in mi...
Objective: Pharmacological LXR activation has anti-atherosclerotic actions in animal models. Part of...
Objective: Pharmacological LXR activation has anti-atherosclerotic actions in animal models. Part of...
The oxysterol-activated liver X receptor (LXR) provides a link between sterol and fatty acid metabol...
Objective: Pharmacological LXR activation has anti-atherosclerotic actions in animal models. Part of...
The oxysterol-activated liver X receptor (LXR) provides a link between sterol and fatty acid metabol...
The oxysterol-activated liver X receptor (LXR) provides a link between sterol and fatty acid metabol...
Objective: Pharmacological LXR activation has anti-atherosclerotic actions in animal models. Part of...
The oxysterol-activated liver X receptor (LXR) provides a link between sterol and fatty acid metabol...
The oxysterol-activated liver X receptor (LXR) provides a link between sterol and fatty acid metabol...
The nuclear liver X receptor (LXR) regulates multiple aspects of cholesterol, triacylglycerol (TG), ...
The nuclear liver X receptor (LXR) regulates multiple aspects of cholesterol, triacylglycerol (TG), ...
The nuclear liver X receptor (LXR) regulates multiple aspects of cholesterol, triacylglycerol (TG), ...
The nuclear liver X receptor (LXR) regulates multiple aspects of cholesterol, triacylglycerol (TG), ...
International audienceThis study explores the mechanisms responsible for the fatty liver setup in mi...
International audienceThis study explores the mechanisms responsible for the fatty liver setup in mi...
Objective: Pharmacological LXR activation has anti-atherosclerotic actions in animal models. Part of...
Objective: Pharmacological LXR activation has anti-atherosclerotic actions in animal models. Part of...
The oxysterol-activated liver X receptor (LXR) provides a link between sterol and fatty acid metabol...
Objective: Pharmacological LXR activation has anti-atherosclerotic actions in animal models. Part of...
The oxysterol-activated liver X receptor (LXR) provides a link between sterol and fatty acid metabol...
The oxysterol-activated liver X receptor (LXR) provides a link between sterol and fatty acid metabol...
Objective: Pharmacological LXR activation has anti-atherosclerotic actions in animal models. Part of...